Focal adhesion kinase: A prominent determinant in breast cancer initiation, progression and metastasis

Cancer Letters

Volumn 289, Issue 2, 2010, Pages 127-139

  Luo, Ming ^a   Guan, Jun Lin ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Breast cancer; Cancer stem cells; FAK; Mouse models; Signaling

Indexed keywords

FOCAL ADHESION KINASE;

AUTOPHOSPHORYLATION; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL; CANCER GROWTH; CANCER SURVIVAL; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SPREADING; CELL SURVIVAL; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; GENE AMPLIFICATION; GENE DELETION; GENE OVEREXPRESSION; GENETIC ENGINEERING; HUMAN; IMMUNE DEFICIENCY; METASTASIS; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SHORT SURVEY; SIGNAL TRANSDUCTION; STEM CELL; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS; RODENTIA;

EID: 76849100707     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.07.005     Document Type: Review

References (174)

1. Guarneri V., and Conte P.F. The curability of breast cancer and the treatment of advanced disease. European Journal of Nuclear Medicine and Molecular Imaging 31 Suppl. 1 (2004) S149-161
2. Guo W., and Giancotti F.G. Integrin signalling during tumour progression. Nature Reviews 5 (2004) 816-826
3. White D.E., and Muller W.J. Multifaceted roles of integrins in breast cancer metastasis. Journal of Mammary Gland Biology and Neoplasia 12 (2007) 135-142
4. Parsons J.T. Focal adhesion kinase: the first ten years. Journal of Cell Science 116 (2003) 1409-1416
5. Brown M.C., Cary L.A., Jamieson J.S., Cooper J.A., and Turner C.E. Src and FAK kinases cooperate to phosphorylate paxillin kinase linker, stimulate its focal adhesion localization, and regulate cell spreading and protrusiveness. Molecular Biology of the Cell 16 (2005) 4316-4328
6. Richardson A., Malik R.K., Hildebrand J.D., and Parsons J.T. Inhibition of cell spreading by expression of the C-terminal domain of focal adhesion kinase (FAK) is rescued by coexpression of Src or catalytically inactive FAK: a role for paxillin tyrosine phosphorylation. Molecular and Cellular Biology 17 (1997) 6906-6914
7. Partridge M.A., and Marcantonio E.E. Initiation of attachment and generation of mature focal adhesions by integrin-containing filopodia in cell spreading. Molecular Biology of the Cell 17 (2006) 4237-4248
8. Thamilselvan V., Craig D.H., and Basson M.D. FAK association with multiple signal proteins mediates pressure-induced colon cancer cell adhesion via a Src-dependent PI3K/Akt pathway. FASEB Journal 21 (2007) 1730-1741
9. Maung K., Easty D.J., Hill S.P., and Bennett D.C. Requirement for focal adhesion kinase in tumor cell adhesion. Oncogene 18 (1999) 6824-6828
10. Kornberg L., Earp H.S., Parsons J.T., Schaller M., and Juliano R.L. Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase. The Journal of Biological Chemistry 267 (1992) 23439-23442
11. Burridge K., Turner C.E., and Romer L.H. Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly. The Journal of Cell Biology 119 (1992) 893-903
12. von Sengbusch A., Gassmann P., Fisch K.M., Enns A., Nicolson G.L., and Haier J. Focal adhesion kinase regulates metastatic adhesion of carcinoma cells within liver sinusoids. The American Journal of Pathology 166 (2005) 585-596
13. Owen J.D., Ruest P.J., Fry D.W., and Hanks S.K. Induced focal adhesion kinase (FAK) expression in FAK-null cells enhances cell spreading and migration requiring both auto- and activation loop phosphorylation sites and inhibits adhesion-dependent tyrosine phosphorylation of Pyk2. Molecular and Cellular Biology 19 (1999) 4806-4818
14. Cary L.A., Chang J.F., and Guan J.L. Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. Journal of Cell Science 109 Pt 7 (1996) 1787-1794
15. Gates R.E., King Jr. L.E., Hanks S.K., and Nanney L.B. Potential role for focal adhesion kinase in migrating and proliferating keratinocytes near epidermal wounds and in culture. Cell Growth and Differentiation 5 (1994) 891-899
16. Ilic D., Furuta Y., Kanazawa S., Takeda N., Sobue K., Nakatsuji N., Nomura S., Fujimoto J., Okada M., and Yamamoto T. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377 (1995) 539-544
17. Sieg D.J., Hauck C.R., and Schlaepfer D.D. Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. Journal of Cell Science 112 Pt 16 (1999) 2677-2691
18. Schlaepfer D.D., Mitra S.K., and Ilic D. Control of motile and invasive cell phenotypes by focal adhesion kinase. Biochimica et Biophysica Acta 1692 (2004) 77-102
19. Hauck C.R., Hsia D.A., Puente X.S., Cheresh D.A., and Schlaepfer D.D. FRNK blocks v-Src-stimulated invasion and experimental metastases without effects on cell motility or growth. The EMBO Journal 21 (2002) 6289-6302
20. Hsia D.A., Mitra S.K., Hauck C.R., Streblow D.N., Nelson J.A., Ilic D., Huang S., Li E., Nemerow G.R., Leng J., Spencer K.S., Cheresh D.A., and Schlaepfer D.D. Differential regulation of cell motility and invasion by FAK. The Journal of Cell Biology 160 (2003) 753-767
21. Schlaepfer D.D., and Mitra S.K. Multiple connections link FAK to cell motility and invasion. Current Opinion in Genetics and Development 14 (2004) 92-101
22. Westhoff M.A., Serrels B., Fincham V.J., Frame M.C., and Carragher N.O. SRC-mediated phosphorylation of focal adhesion kinase couples actin and adhesion dynamics to survival signaling. Molecular and Cellular Biology 24 (2004) 8113-8133
23. van de Water B., Houtepen F., Huigsloot M., and Tijdens I.B. Suppression of chemically induced apoptosis but not necrosis of renal proximal tubular epithelial (LLC-PK1) cells by focal adhesion kinase (FAK). Role of FAK in maintaining focal adhesion organization after acute renal cell injury. The Journal of Biological Chemistry 276 (2001) 36183-36193
24. Ilic D., Almeida E.A., Schlaepfer D.D., Dazin P., Aizawa S., and Damsky C.H. Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis. The Journal of Cell Biology 143 (1998) 547-560
25. Frisch S.M., Vuori K., Ruoslahti E., and Chan-Hui P.Y. Control of adhesion-dependent cell survival by focal adhesion kinase. The Journal of Cell Biology 134 (1996) 793-799
26. Hungerford J.E., Compton M.T., Matter M.L., Hoffstrom B.G., and Otey C.A. Inhibition of pp125FAK in cultured fibroblasts results in apoptosis. The Journal of Cell Biology 135 (1996) 1383-1390
27. Xu L.H., Yang X., Bradham C.A., Brenner D.A., Baldwin Jr. A.S., Craven R.J., and Cance W.G. The focal adhesion kinase suppresses transformation-associated, anchorage-independent apoptosis in human breast cancer cells. Involvement of death receptor-related signaling pathways. The Journal of Biological Chemistry 275 (2000) 30597-30604
28. Duxbury M.S., Ito H., Zinner M.J., Ashley S.W., and Whang E.E. Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells. Surgery 135 (2004) 555-562
29. Braren R., Hu H., Kim Y.H., Beggs H.E., Reichardt L.F., and Wang R. Endothelial FAK is essential for vascular network stability, cell survival, and lamellipodial formation. The Journal of Cell Biology 172 (2006) 151-162
30. Wang D., Grammer J.R., Cobbs C.S., Stewart Jr. J.E., Liu Z., Rhoden R., Hecker T.P., Ding Q., and Gladson C.L. p125 focal adhesion kinase promotes malignant astrocytoma cell proliferation in vivo. Journal of Cell Science 113 Pt 23 (2000) 4221-4230
31. Zhao J.H., Reiske H., and Guan J.L. Regulation of the cell cycle by focal adhesion kinase. The Journal of Cell Biology 143 (1998) 1997-2008
32. Oktay M., Wary K.K., Dans M., Birge R.B., and Giancotti F.G. Integrin-mediated activation of focal adhesion kinase is required for signaling to Jun NH2-terminal kinase and progression through the G1 phase of the cell cycle. The Journal of Cell Biology 145 (1999) 1461-1469
33. Zhao J., Pestell R., and Guan J.L. Transcriptional activation of cyclin D1 promoter by FAK contributes to cell cycle progression. Molecular Biology of the Cell 12 (2001) 4066-4077
34. Nagy T., Wei H., Shen T.L., Peng X., Liang C.C., Gan B., and Guan J.L. Mammary epithelial-specific deletion of the focal adhesion kinase gene leads to severe lobulo-alveolar hypoplasia and secretory immaturity of the murine mammary gland. The Journal of Biological Chemistry 282 (2007) 31766-31776
35. Peng X., Ueda H., Zhou H., Stokol T., Shen T.L., Alcaraz A., Nagy T., Vassalli J.D., and Guan J.L. Overexpression of focal adhesion kinase in vascular endothelial cells promotes angiogenesis in transgenic mice. Cardiovascular Research 64 (2004) 421-430
36. Shen T.L., Park A.Y., Alcaraz A., Peng X., Jang I., Koni P., Flavell R.A., Gu H., and Guan J.L. Conditional knockout of focal adhesion kinase in endothelial cells reveals its role in angiogenesis and vascular development in late embryogenesis. The Journal of Cell Biology 169 (2005) 941-952
37. Schaller M.D., Borgman C.A., Cobb B.S., Vines R.R., Reynolds A.B., and Parsons J.T. pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proceedings of the National Academy of Sciences of the United States of America 89 (1992) 5192-5196
38. Guan J.L., Trevithick J.E., and Hynes R.O. Fibronectin/integrin interaction induces tyrosine phosphorylation of a 120-kDa protein. Cell Regulation 2 (1991) 951-964
39. Guan J.L., and Shalloway D. Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation. Nature 358 (1992) 690-692
40. Sieg D.J., Hauck C.R., Ilic D., Klingbeil C.K., Schaefer E., Damsky C.H., and Schlaepfer D.D. FAK integrates growth-factor and integrin signals to promote cell migration. Nature Cell Biology 2 (2000) 249-256
41. Matsumoto K., Matsumoto K., Nakamura T., and Kramer R.H. Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. The Journal of Biological Chemistry 269 (1994) 31807-31813
42. Schlaepfer D.D., Hou S., Lim S.T., Tomar A., Yu H., Lim Y., Hanson D.A., Uryu S.A., Molina J., and Mitra S.K. Tumor necrosis factor-alpha stimulates focal adhesion kinase activity required for mitogen-activated kinase-associated interleukin 6 expression. The Journal of Biological Chemistry 282 (2007) 17450-17459
43. Fan R.S., Jacamo R.O., Jiang X., Sinnett-Smith J., and Rozengurt E. G protein-coupled receptor activation rapidly stimulates focal adhesion kinase phosphorylation at Ser-843. Mediation by Ca2+, calmodulin, and Ca2+/calmodulin-dependent kinase II. The Journal of Biological Chemistry 280 (2005) 24212-24220
44. Seufferlein T., and Rozengurt E. Sphingosine induces p125FAK and paxillin tyrosine phosphorylation, actin stress fiber formation, and focal contact assembly in Swiss 3T3 cells. The Journal of Biological Chemistry 269 (1994) 27610-27617
45. Navarro-Tito N., Robledo T., and Salazar E.P. Arachidonic acid promotes FAK activation and migration in MDA-MB-231 breast cancer cells. Experimental Cell Research 314 (2008) 3340-3355
46. Schaller M.D., Hildebrand J.D., Shannon J.D., Fox J.W., Vines R.R., and Parsons J.T. Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src. Molecular and Cellular Biology 14 (1994) 1680-1688
47. Xing Z., Chen H.C., Nowlen J.K., Taylor S.J., Shalloway D., and Guan J.L. Direct interaction of v-Src with the focal adhesion kinase mediated by the Src SH2 domain. Molecular Biology of the Cell 5 (1994) 413-421
48. Chen H.C., and Guan J.L. Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase. Proceedings of the National Academy of Sciences of the United States of America 91 (1994) 10148-10152
49. Chen H.C., Appeddu P.A., Isoda H., and Guan J.L. Phosphorylation of tyrosine 397 in focal adhesion kinase is required for binding phosphatidylinositol 3-kinase. The Journal of Biological Chemistry 271 (1996) 26329-26334
50. Han D.C., and Guan J.L. Association of focal adhesion kinase with Grb7 and its role in cell migration. The Journal of Biological Chemistry 274 (1999) 24425-24430
51. Han D.C., Shen T.L., and Guan J.L. Role of Grb7 targeting to focal contacts and its phosphorylation by focal adhesion kinase in regulation of cell migration. The Journal of Biological Chemistry 275 (2000) 28911-28917
52. Barberis L., Wary K.K., Fiucci G., Liu F., Hirsch E., Brancaccio M., Altruda F., Tarone G., and Giancotti F.G. Distinct roles of the adaptor protein Shc and focal adhesion kinase in integrin signaling to ERK. The Journal of Biological Chemistry 275 (2000) 36532-36540
53. Carloni V., Romanelli R.G., Pinzani M., Laffi G., and Gentilini P. Focal adhesion kinase and phospholipase C gamma involvement in adhesion and migration of human hepatic stellate cells. Gastroenterology 112 (1997) 522-531
54. Zhang X., Chattopadhyay A., Ji Q.S., Owen J.D., Ruest P.J., Carpenter G., and Hanks S.K. Focal adhesion kinase promotes phospholipase C-gamma1 activity. Proceedings of the National Academy of Sciences of the United States of America 96 (1999) 9021-9026
55. Calalb M.B., Polte T.R., and Hanks S.K. Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Molecular and Cellular Biology 15 (1995) 954-963
56. Eliceiri B.P., Puente X.S., Hood J.D., Stupack D.G., Schlaepfer D.D., Huang X.Z., Sheppard D., and Cheresh D.A. Src-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signaling. The Journal of Cell Biology 157 (2002) 149-160
57. Schlaepfer D.D., Hanks S.K., Hunter T., and van der Geer P. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 372 (1994) 786-791
58. Polte T.R., and Hanks S.K. Interaction between focal adhesion kinase and Crk-associated tyrosine kinase substrate p130Cas. Proceedings of the National Academy of Sciences of the United States of America 92 (1995) 10678-10682
59. Hildebrand J.D., Taylor J.M., and Parsons J.T. An SH3 domain-containing GTPase-activating protein for Rho and Cdc42 associates with focal adhesion kinase. Molecular and Cellular Biology 16 (1996) 3169-3178
60. Liu Y., Loijens J.C., Martin K.H., Karginov A.V., and Parsons J.T. The association of ASAP1, an ADP ribosylation factor-GTPase activating protein, with focal adhesion kinase contributes to the process of focal adhesion assembly. Molecular Biology of the Cell 13 (2002) 2147-2156
61. Wu X., Gan B., Yoo Y., and Guan J.L. FAK-mediated src phosphorylation of endophilin A2 inhibits endocytosis of MT1-MMP and promotes ECM degradation. Developmental Cell 9 (2005) 185-196
62. Gotoh A., Miyazawa K., Ohyashiki K., Tauchi T., Boswell H.S., Broxmeyer H.E., and Toyama K. Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein. Experimental Hematology 23 (1995) 1153-1159
63. Akagi T., Murata K., Shishido T., and Hanafusa H. v-Crk activates the phosphoinositide 3-kinase/AKT pathway by utilizing focal adhesion kinase and H-Ras. Molecular and Cellular Biology 22 (2002) 7015-7023
64. Benlimame N., He Q., Jie S., Xiao D., Xu Y.J., Loignon M., Schlaepfer D.D., and Alaoui-Jamali M.A. FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion. The Journal of Cell Biology 171 (2005) 505-516
65. Lim Y., Han I., Jeon J., Park H., Bahk Y.Y., and Oh E.S. Phosphorylation of focal adhesion kinase at tyrosine 861 is crucial for Ras transformation of fibroblasts. The Journal of Biological Chemistry 279 (2004) 29060-29065
66. Golubovskaya V.M., Kweh F.A., and Cance W.G. Focal adhesion kinase and cancer. Histology and Histopathology 24 (2009) 503-510
67. Zhao J., and Guan J.L. Signal transduction by focal adhesion kinase in cancer. Cancer Metastasis Reviews 28 (2009) 35-49
68. Owens L.V., Xu L., Craven R.J., Dent G.A., Weiner T.M., Kornberg L., Liu E.T., and Cance W.G. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Research 55 (1995) 2752-2755
69. Oktay M.H., Oktay K., Hamele-Bena D., Buyuk A., and Koss L.G. Focal adhesion kinase as a marker of malignant phenotype in breast and cervical carcinomas. Human Pathology 34 (2003) 240-245
70. Lightfoot Jr. H.M., Lark A., Livasy C.A., Moore D.T., Cowan D., Dressler L., Craven R.J., and Cance W.G. Upregulation of focal adhesion kinase (FAK) expression in ductal carcinoma in situ (DCIS) is an early event in breast tumorigenesis. Breast Cancer Research and Treatment 88 (2004) 109-116
71. Cance W.G., Harris J.E., Iacocca M.V., Roche E., Yang X., Chang J., Simkins S., and Xu L. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clinical Cancer Research 6 (2000) 2417-2423
72. Watermann D.O., Gabriel B., Jager M., Orlowska-Volk M., Hasenburg A., zur Hausen A., Gitsch G., and Stickeler E. Specific induction of pp125 focal adhesion kinase in human breast cancer. British Journal of Cancer 93 (2005) 694-698
73. Lark A.L., Livasy C.A., Dressler L., Moore D.T., Millikan R.C., Geradts J., Iacocca M., Cowan D., Little D., Craven R.J., and Cance W. High focal adhesion kinase expression in invasive breast carcinomas is associated with an aggressive phenotype. Modern Pathology 18 (2005) 1289-1294
74. Pylayeva Y., Gillen K.M., Gerald W., Beggs H.E., Reichardt L.F., and Giancotti F.G. Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling. The Journal of Clinical Investigation 119 (2009) 252-266
75. Agochiya M., Brunton V.G., Owens D.W., Parkinson E.K., Paraskeva C., Keith W.N., and Frame M.C. Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells. Oncogene 18 (1999) 5646-5653
76. Madan R., Smolkin M.B., Cocker R., Fayyad R., and Oktay M.H. Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma. Human Pathology 37 (2006) 9-15
77. Ayaki M., Komatsu K., Mukai M., Murata K., Kameyama M., Ishiguro S., Miyoshi J., Tatsuta M., and Nakamura H. Reduced expression of focal adhesion kinase in liver metastases compared with matched primary human colorectal adenocarcinomas. Clinical Cancer Research 7 (2001) 3106-3112
78. Gabriel B., zur Hausen A., Stickeler E., Dietz C., Gitsch G., Fischer D.C., Bouda J., Tempfer C., and Hasenburg A. Weak expression of focal adhesion kinase (pp125FAK) in patients with cervical cancer is associated with poor disease outcome. Clinical Cancer Research 12 (2006) 2476-2483
79. Canel M., Secades P., Rodrigo J.P., Cabanillas R., Herrero A., Suarez C., and Chiara M.D. Overexpression of focal adhesion kinase in head and neck squamous cell carcinoma is independent of fak gene copy number. Clinical Cancer Research 12 (2006) 3272-3279
80. Golubovskaya V., Kaur A., and Cance W. Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor kappa B and p53 binding sites. Biochimica et Biophysica Acta 1678 (2004) 111-125
81. Golubovskaya V.M., and Cance W.G. Focal adhesion kinase and p53 signaling in cancer cells. International Review of Cytology 263 (2007) 103-153
82. Golubovskaya V.M., Finch R., Kweh F., Massoll N.A., Campbell-Thompson M., Wallace M.R., and Cance W.G. p53 regulates FAK expression in human tumor cells. Molecular Carcinogenesis 47 (2008) 373-382
83. Sonoda Y., Matsumoto Y., Funakoshi M., Yamamoto D., Hanks S.K., and Kasahara T. Anti-apoptotic role of focal adhesion kinase (FAK). Induction of inhibitor-of-apoptosis proteins and apoptosis suppression by the overexpression of FAK in a human leukemic cell line, HL-60. The Journal of Biological Chemistry 275 (2000) 16309-16315
84. Liu X.J., Yang L., Wu H.B., Qiang O., Huang M.H., and Wang Y.P. Apoptosis of rat hepatic stellate cells induced by anti-focal adhesion kinase antibody. World Journal of Gastroenterology 8 (2002) 734-738
85. Xu L.H., Owens L.V., Sturge G.C., Yang X., Liu E.T., Craven R.J., and Cance W.G. Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells. Cell Growth and Differentiation 7 (1996) 413-418
86. Jones G., Machado Jr. J., Tolnay M., and Merlo A. PTEN-independent induction of caspase-mediated cell death and reduced invasion by the focal adhesion targeting domain (FAT) in human astrocytic brain tumors which highly express focal adhesion kinase (FAK). Cancer Research 61 (2001) 5688-5691
87. Kurenova E., Xu L.H., Yang X., Baldwin Jr. A.S., Craven R.J., Hanks S.K., Liu Z.G., and Cance W.G. Focal adhesion kinase suppresses apoptosis by binding to the death domain of receptor-interacting protein. Molecular and Cellular Biology 24 (2004) 4361-4371
88. Golubovskaya V., Beviglia L., Xu L.H., Earp III H.S., Craven R., and Cance W. Dual inhibition of focal adhesion kinase and epidermal growth factor receptor pathways cooperatively induces death receptor-mediated apoptosis in human breast cancer cells. The Journal of Biological Chemistry 277 (2002) 38978-38987
89. Chen S.Y., and Chen H.C. Direct interaction of focal adhesion kinase (FAK) with Met is required for FAK to promote hepatocyte growth factor-induced cell invasion. Molecular and Cellular Biology 26 (2006) 5155-5167
90. Garces C.A., Kurenova E.V., Golubovskaya V.M., and Cance W.G. Vascular endothelial growth factor receptor-3 and focal adhesion kinase bind and suppress apoptosis in breast cancer cells. Cancer Research 66 (2006) 1446-1454
91. Xu L.H., Yang X., Craven R.J., and Cance W.G. The COOH-terminal domain of the focal adhesion kinase induces loss of adhesion and cell death in human tumor cells. Cell Growth and Differentiation 9 (1998) 999-1005
92. Wang S.E., Xiang B., Zent R., Quaranta V., Pozzi A., and Arteaga C.L. Transforming growth factor beta induces clustering of HER2 and integrins by activating Src-focal adhesion kinase and receptor association to the cytoskeleton. Cancer Research 69 (2009) 475-482
93. Reiske H.R., Kao S.C., Cary L.A., Guan J.L., Lai J.F., and Chen H.C. Requirement of phosphatidylinositol 3-kinase in focal adhesion kinase-promoted cell migration. The Journal of Biological Chemistry 274 (1999) 12361-12366
94. Luo J., Manning B.D., and Cantley L.C. Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 4 (2003) 257-262
95. Hennessy B.T., Smith D.L., Ram P.T., Lu Y., and Mills G.B. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nature Reviews Drug Discovery 4 (2005) 988-1004
96. Chan P.C., Lai J.F., Cheng C.H., Tang M.J., Chiu C.C., and Chen H.C. Suppression of ultraviolet irradiation-induced apoptosis by overexpression of focal adhesion kinase in Madin-Darby canine kidney cells. The Journal of Biological Chemistry 274 (1999) 26901-26906
97. Golubovskaya V.M., Finch R., and Cance W.G. Direct interaction of the N-terminal domain of focal adhesion kinase with the N-terminal transactivation domain of p53. The Journal of Biological Chemistry 280 (2005) 25008-25021
98. Lim S.T., Chen X.L., Lim Y., Hanson D.A., Vo T.T., Howerton K., Larocque N., Fisher S.J., Schlaepfer D.D., and Ilic D. Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation. Molecular Cell 29 (2008) 9-22
99. Zhao J., Bian Z.C., Yee K., Chen B.P., Chien S., and Guan J.L. Identification of transcription factor KLF8 as a downstream target of focal adhesion kinase in its regulation of cyclin D1 and cell cycle progression. Molecular Cell 11 (2003) 1503-1515
100. Aguirre Ghiso J.A. Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo. Oncogene 21 (2002) 2513-2524
101. Provenzano P.P., Inman D.R., Eliceiri K.W., Beggs H.E., and Keely P.J. Mammary epithelial-specific disruption of focal adhesion kinase retards tumor formation and metastasis in a transgenic mouse model of human breast cancer. The American Journal of Pathology 173 (2008) 1551-1565
102. Luo M., Fan H., Nagy T., Wei H., Wang C., Liu S., Wicha M.S., and Guan J.L. Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem/progenitor cells. Cancer Research 69 (2009) 466-474
103. Webb D.J., Donais K., Whitmore L.A., Thomas S.M., Turner C.E., Parsons J.T., and Horwitz A.F. FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nature Cell Biology 6 (2004) 154-161
104. Schober M., Raghavan S., Nikolova M., Polak L., Pasolli H.A., Beggs H.E., Reichardt L.F., and Fuchs E. Focal adhesion kinase modulates tension signaling to control actin and focal adhesion dynamics. The Journal of Cell Biology 176 (2007) 667-680
105. Hiscox S., Jordan N.J., Morgan L., Green T.P., and Nicholson R.I. Src kinase promotes adhesion-independent activation of FAK and enhances cellular migration in tamoxifen-resistant breast cancer cells. Clinical and Experimental Metastasis 24 (2007) 157-167
106. Mitra S.K., and Schlaepfer D.D. Integrin-regulated FAK-Src signaling in normal and cancer cells. Current Opinion in Cell Biology 18 (2006) 516-523
107. Cary L.A., Han D.C., Polte T.R., Hanks S.K., and Guan J.L. Identification of p130Cas as a mediator of focal adhesion kinase-promoted cell migration. The Journal of Cell Biology 140 (1998) 211-221
108. Klemke R.L., Leng J., Molander R., Brooks P.C., Vuori K., and Cheresh D.A. CAS/Crk coupling serves as a "molecular switch" for induction of cell migration. The Journal of Cell Biology 140 (1998) 961-972
109. Carragher N.O., Westhoff M.A., Fincham V.J., Schaller M.D., and Frame M.C. A novel role for FAK as a protease-targeting adaptor protein: regulation by p42 ERK and Src. Current Biology 13 (2003) 1442-1450
110. Sawhney R.S., Liu W., and Brattain M.G. A novel role of ERK5 in integrin-mediated cell adhesion and motility in cancer cells via Fak signaling. Journal of Cellular Physiology 219 (2009) 152-161
111. Chu P.Y., Huang L.Y., Hsu C.H., Liang C.C., Guan J.L., Hung T.H., and Shen T.L. Tyrosine phosphorylation of Grb7 by FAK in the regulation of cell migration, proliferation, and tumorigenesis. The Journal of Biological Chemistry (2009)
112. Chen B.H., Tzen J.T., Bresnick A.R., and Chen H.C. Roles of Rho-associated kinase and myosin light chain kinase in morphological and migratory defects of focal adhesion kinase-null cells. The Journal of Biological Chemistry 277 (2002) 33857-33863
113. Ren X.D., Kiosses W.B., Sieg D.J., Otey C.A., Schlaepfer D.D., and Schwartz M.A. Focal adhesion kinase suppresses Rho activity to promote focal adhesion turnover. Journal of Cell Science 113 Pt 20 (2000) 3673-3678
114. Wu X., Suetsugu S., Cooper L.A., Takenawa T., and Guan J.L. Focal adhesion kinase regulation of N-WASP subcellular localization and function. The Journal of Biological Chemistry 279 (2004) 9565-9576
115. Serrels B., Serrels A., Brunton V.G., Holt M., McLean G.W., Gray C.H., Jones G.E., and Frame M.C. Focal adhesion kinase controls actin assembly via a FERM-mediated interaction with the Arp2/3 complex. Nature Cell Biology 9 (2007) 1046-1056
116. McLean G.W., Carragher N.O., Avizienyte E., Evans J., Brunton V.G., and Frame M.C. The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. Nature Reviews Cancer 5 (2005) 505-515
117. Cohen L.A., and Guan J.L. Mechanisms of focal adhesion kinase regulation. Current Cancer Drug Targets 5 (2005) 629-643
118. Earley S., and Plopper G.E. Disruption of focal adhesion kinase slows transendothelial migration of AU-565 breast cancer cells. Biochemical and Biophysical Research Communications 350 (2006) 405-412
119. Earley S., and Plopper G.E. Phosphorylation of focal adhesion kinase promotes extravasation of breast cancer cells. Biochemical and Biophysical Research Communications 366 (2008) 476-482
120. Kallergi G., Mavroudis D., Georgoulias V., Stournaras C., and FAK P.o. Phosphorylation of FAK, PI-3K, and impaired actin organization in CK-positive micrometastatic breast cancer cells. Molecular Medicine 13 (2007) 79-88
121. Vepa S., Scribner W.M., Parinandi N.L., English D., Garcia J.G., and Natarajan V. Hydrogen peroxide stimulates tyrosine phosphorylation of focal adhesion kinase in vascular endothelial cells. The American Journal of Physiology 277 (1999) L150-158
122. Gozin A., Franzini E., Andrieu V., Da Costa L., Rollet-Labelle E., and Pasquier C. Reactive oxygen species activate focal adhesion kinase, paxillin and p130cas tyrosine phosphorylation in endothelial cells. Free Radical Biology and Medicine 25 (1998) 1021-1032
123. Schaphorst K.L., Pavalko F.M., Patterson C.E., and Garcia J.G. Thrombin-mediated focal adhesion plaque reorganization in endothelium: role of protein phosphorylation. American Journal of Respiratory Cell and Molecular Biology 17 (1997) 443-455
124. Wu M.H., Guo M., Yuan S.Y., and Granger H.J. Focal adhesion kinase mediates porcine venular hyperpermeability elicited by vascular endothelial growth factor. The Journal of Physiology 552 (2003) 691-699
125. Yuan Y., Meng F.Y., Huang Q., Hawker J., and Wu H.M. Tyrosine phosphorylation of paxillin/pp125FAK and microvascular endothelial barrier function. The American Journal of Physiology 275 (1998) H84-93
126. Xu Y., Benlimame N., Su J., He Q., and Alaoui-Jamali M.A. Regulation of focal adhesion turnover by ErbB signalling in invasive breast cancer cells. British Journal of Cancer 100 (2009) 633-643
127. Buccione R., Orth J.D., and McNiven M.A. Foot and mouth: podosomes, invadopodia and circular dorsal ruffles. Nature Reviews 5 (2004) 647-657
128. Weaver A.M. Invadopodia: specialized cell structures for cancer invasion. Clinical and Experimental Metastasis 23 (2006) 97-105
129. Chan K.T., Cortesio C.L., and Huttenlocher A. FAK alters invadopodia and focal adhesion composition and dynamics to regulate breast cancer invasion. The Journal of Cell Biology 185 (2009) 357-370
130. Shibata K., Kikkawa F., Nawa A., Thant A.A., Naruse K., Mizutani S., and Hamaguchi M. Both focal adhesion kinase and c-Ras are required for the enhanced matrix metalloproteinase 9 secretion by fibronectin in ovarian cancer cells. Cancer Research 58 (1998) 900-903
131. Irby R.B., and Yeatman T.J. Increased Src activity disrupts cadherin/catenin-mediated homotypic adhesion in human colon cancer and transformed rodent cells. Cancer Research 62 (2002) 2669-2674
132. Avizienyte E., and Frame M.C. Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition. Current Opinion in Cell Biology 17 (2005) 542-547
133. Avizienyte E., Wyke A.W., Jones R.J., McLean G.W., Westhoff M.A., Brunton V.G., and Frame M.C. Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling. Nature Cell Biology 4 (2002) 632-638
134. Strizzi L., Bianco C., Normanno N., Seno M., Wechselberger C., Wallace-Jones B., Khan N.I., Hirota M., Sun Y., Sanicola M., and Salomon D.S. Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice. Journal of Cellular Physiology 201 (2004) 266-276
135. Nakamura K., Yano H., Schaefer E., and Sabe H. Different modes and qualities of tyrosine phosphorylation of Fak and Pyk2 during epithelial-mesenchymal transdifferentiation and cell migration: analysis of specific phosphorylation events using site-directed antibodies. Oncogene 20 (2001) 2626-2635
136. Bailey K.M., and Liu J. Caveolin-1 up-regulation during epithelial to mesenchymal transition is mediated by focal adhesion kinase. The Journal of Biological Chemistry 283 (2008) 13714-13724
137. Cicchini C., Laudadio I., Citarella F., Corazzari M., Steindler C., Conigliaro A., Fantoni A., Amicone L., and Tripodi M. TGFbeta-induced EMT requires focal adhesion kinase (FAK) signaling. Experimental Cell Research 314 (2008) 143-152
138. Prunier C., and Howe P.H. Disabled-2 (Dab2) is required for transforming growth factor beta-induced epithelial to mesenchymal transition (EMT). The Journal of Biological Chemistry 280 (2005) 17540-17548
139. Rodrigo J.P., Dominguez F., Suarez V., Canel M., Secades P., and Chiara M.D. Focal adhesion kinase and E-cadherin as markers for nodal metastasis in laryngeal cancer. Archives of Otolaryngology - Head and Neck Surgery 133 (2007) 145-150
140. Haskell H., Natarajan M., Hecker T.P., Ding Q., Stewart Jr. J., Grammer J.R., and Gladson C.L. Focal adhesion kinase is expressed in the angiogenic blood vessels of malignant astrocytic tumors in vivo and promotes capillary tube formation of brain microvascular endothelial cells. Clinical Cancer Research 9 (2003) 2157-2165
141. Eliceiri B.P., and Cheresh D.A. The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development. The Journal of Clinical Investigation 103 (1999) 1227-1230
142. Brooks P.C., Montgomery A.M., Rosenfeld M., Reisfeld R.A., Hu T., Klier G., and Cheresh D.A. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79 (1994) 1157-1164
143. Brooks P.C., Stromblad S., Klemke R., Visscher D., Sarkar F.H., and Cheresh D.A. Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. The Journal of Clinical Investigation 96 (1995) 1815-1822
144. Mitra S.K., Mikolon D., Molina J.E., Hsia D.A., Hanson D.A., Chi A., Lim S.T., Bernard-Trifilo J.A., Ilic D., Stupack D.G., Cheresh D.A., and Schlaepfer D.D. Intrinsic FAK activity and Y925 phosphorylation facilitate an angiogenic switch in tumors. Oncogene 25 (2006) 5969-5984
145. Park A.Y., Shen T.L., Chien S., and Guan J.L. Role of focal adhesion kinase Ser-732 phosphorylation in centrosome function during mitosis. The Journal of Biological Chemistry 284 (2009) 9418-9425
146. van Nimwegen M.J., Verkoeijen S., van Buren L., Burg D., and van de Water B. Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation. Cancer Research 65 (2005) 4698-4706
147. Mitra S.K., Lim S.T., Chi A., and Schlaepfer D.D. Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model. Oncogene 25 (2006) 4429-4440
148. Behmoaram E., Bijian K., Jie S., Xu Y., Darnel A., Bismar T.A., and Alaoui-Jamali M.A. Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness. The American Journal of Pathology 173 (2008) 1540-1550
149. Vargo-Gogola T., and Rosen J.M. Modelling breast cancer: one size does not fit all. Nature Reviews Cancer 7 (2007) 659-672
150. Lin E.Y., Jones J.G., Li P., Zhu L., Whitney K.D., Muller W.J., and Pollard J.W. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. The American Journal of Pathology 163 (2003) 2113-2126
151. Lahlou H., Sanguin-Gendreau V., Zuo D., Cardiff R.D., McLean G.W., Frame M.C., and Muller W.J. Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression. Proceedings of the National Academy of Sciences of the United States of America 104 (2007) 20302-20307
152. Maglione J.E., Moghanaki D., Young L.J., Manner C.K., Ellies L.G., Joseph S.O., Nicholson B., Cardiff R.D., and MacLeod C.L. Transgenic polyoma middle-T mice model premalignant mammary disease. Cancer Research 61 (2001) 8298-8305
153. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., and Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America 100 (2003) 3983-3988
154. Prince M.E., Sivanandan R., Kaczorowski A., Wolf G.T., Kaplan M.J., Dalerba P., Weissman I.L., Clarke M.F., and Ailles L.E. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proceedings of the National Academy of Sciences of the United States of America 104 (2007) 973-978
155. O'Brien C.A., Pollett A., Gallinger S., and Dick J.E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445 (2007) 106-110
156. Kim C.F., Jackson E.L., Woolfenden A.E., Lawrence S., Babar I., Vogel S., Crowley D., Bronson R.T., and Jacks T. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121 (2005) 823-835
157. Collins A.T., Berry P.A., Hyde C., Stower M.J., and Maitland N.J. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Research 65 (2005) 10946-10951
158. Bonnet D., and Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine 3 (1997) 730-737
159. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., and Dirks P.B. Identification of human brain tumour initiating cells. Nature 432 (2004) 396-401
160. Fang D., Nguyen T.K., Leishear K., Finko R., Kulp A.N., Hotz S., Van Belle P.A., Xu X., Elder D.E., and Herlyn M. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Research 65 (2005) 9328-9337
161. Li C., Heidt D.G., Dalerba P., Burant C.F., Zhang L., Adsay V., Wicha M., Clarke M.F., and Simeone D.M. Identification of pancreatic cancer stem cells. Cancer Research 67 (2007) 1030-1037
162. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., Biffoni M., Todaro M., Peschle C., and De Maria R. Identification and expansion of human colon-cancer-initiating cells. Nature 445 (2007) 111-115
163. Clarke M.F., Dick J.E., Dirks P.B., Eaves C.J., Jamieson C.H., Jones D.L., Visvader J., Weissman I.L., and Wahl G.M. Cancer stem cells - perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Research 66 (2006) 9339-9344
164. Ponti D., Costa A., Zaffaroni N., Pratesi G., Petrangolini G., Coradini D., Pilotti S., Pierotti M.A., and Daidone M.G. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Research 65 (2005) 5506-5511
165. Dontu G., Abdallah W.M., Foley J.M., Jackson K.W., Clarke M.F., Kawamura M.J., and Wicha M.S. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes and Development 17 (2003) 1253-1270
166. Liao M.J., Zhang C.C., Zhou B., Zimonjic D.B., Mani S.A., Kaba M., Gifford A., Reinhardt F., Popescu N.C., Guo W., Eaton E.N., Lodish H.F., and Weinberg R.A. Enrichment of a population of mammary gland cells that form mammospheres and have in vivo repopulating activity. Cancer Research 67 (2007) 8131-8138
167. Zucchi I., Sanzone S., Astigiano S., Pelucchi P., Scotti M., Valsecchi V., Barbieri O., Bertoli G., Albertini A., Reinbold R.A., and Dulbecco R. The properties of a mammary gland cancer stem cell. Proceedings of the National Academy of Sciences of the United States of America 104 (2007) 10476-10481
168. Stingl J., Eirew P., Ricketson I., Shackleton M., Vaillant F., Choi D., Li H.I., and Eaves C.J. Purification and unique properties of mammary epithelial stem cells. Nature 439 (2006) 993-997
169. Shackleton M., Vaillant F., Simpson K.J., Stingl J., Smyth G.K., Asselin-Labat M.L., Wu L., Lindeman G.J., and Visvader J.E. Generation of a functional mammary gland from a single stem cell. Nature 439 (2006) 84-88
170. Kouros-Mehr H., Bechis S.K., Slorach E.M., Littlepage L.E., Egeblad M., Ewald A.J., Pai S.Y., Ho I.C., and Werb Z. GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Cancer Cell 13 (2008) 141-152
171. Zhang M., Behbod F., Atkinson R.L., Landis M.D., Kittrell F., Edwards D., Medina D., Tsimelzon A., Hilsenbeck S., Green J.E., Michalowska A.M., and Rosen J.M. Identification of tumor-initiating cells in a p53-null mouse model of breast cancer. Cancer Research 68 (2008) 4674-4682
172. Shafee N., Smith C.R., Wei S., Kim Y., Mills G.B., Hortobagyi G.N., Stanbridge E.J., and Lee E.Y. Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors. Cancer Research 68 (2008) 3243-3250
173. Lim S.T., Mikolon D., and Stupack D.G. FERM control of FAK function: implications for cancer therapy. Cell Cycle 7 (2008) 2306-2314
174. Parsons J.T., Slack-Davis J., Tilghman R., and Roberts W.G. Focal adhesion kinase: targeting adhesion signaling pathways for therapeutic intervention. Clinical Cancer Research 14 (2008) 627-632